Croda International PLC - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Croda International PLC


Website: www.croda.com/healthcare

E-mail: hc-europe@croda.com

Croda International Plc is a UK-based manufacturer and worldwide supplier of oleochemicals offering one of the widest ranges of chemical specialties, surfactants, and high-purity lipids available to the pharmaceutical industry with products manufactured at multiple sites throughout the world.

Croda manufactures excipients of superior quality and purity for the global pharmaceutical market. Croda developed and utilises a proprietary flash chromatographic process called Super Refining. This process physically removes impurities from pharmaceutical excipients without altering their fundamental structure in any way. This process allows the offering of a range of high purity excipients that can improve API and formulation stability.

Croda offers a complete range of products for topical dosage forms as well as high-purity multicompendial solvents, solubilisers and surfactants suitable for parenteral, oral and ophthalmic formulations. Featured products include Super Refined ingredients: Oils, Oleic Acid, Oleyl Alcohol, Isopropyl Myristate, PEGs, Polysorbates, Dimethyl Isosorbide, Medical Grade Lanolins, Poloxamers and Omega 3 Fatty Acid Concentrates.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here